Illumina Inc (ILMN) Actualités

Illumina and NVIDIA collaborate to decode biology and propel precision health

Illumina and NVIDIA collaborate to decode biology and propel precision health PR Newswire SAN DIEGO, Jan. 13, 2025 Collaboration combines...

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples PR Newswire SAN DIEGO, Jan. 13...

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025 PR Newswire SAN DIEGO, Jan. 9, 2025 SAN...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to...

Form 4 - Statement of changes in beneficial ownership of securities

Annual Changes to the Nasdaq-100 Index®

NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Illumina To Webcast Upcoming Investor Conference

Illumina To Webcast Upcoming Investor Conference PR Newswire SAN DIEGO, Dec. 4, 2024 SAN DIEGO, Dec. 4, 2024 /PRNewswire/ -- Illumina, Inc...

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications PR Newswire AMSTERDAM, Dec...

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic...

Illumina announces expansion of TruSight Oncology portfolio

Illumina announces expansion of TruSight Oncology portfolio PR Newswire SAN DIEGO, Nov. 19, 2024 The latest...